Company news
Exozymes Inc. (NASDAQ:EXOZ) news
Exozymes Inc. news releases on 6ix. Latest, Sep 8, 2026: eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
Press releases & updates
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
September 8, 2026
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
August 20, 2026
eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
July 22, 2026
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
June 23, 2026
EXoZymes Inc. Announces Closing of $6 Million Public Offering
June 17, 2026
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
June 8, 2026
eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program
May 6, 2026
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
March 31, 2026
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
March 25, 2026
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
March 18, 2026
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
March 12, 2026
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
February 10, 2026
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run
January 29, 2026
eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion
December 11, 2025
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
November 13, 2025
eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff
November 13, 2025
eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST
November 10, 2025
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
October 30, 2025
CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
October 29, 2025
CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference
October 23, 2025
eXoZymes Inc. Partners With B2i Digital to Spotlight the Cell-Free Next Generation of Biomanufacturing
October 14, 2025
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
September 30, 2025
eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today
August 12, 2025
eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST
August 7, 2025
eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity
July 29, 2025
eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months
July 22, 2025
eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing
June 26, 2025
eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast
May 16, 2025
eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today
May 12, 2025
eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST
May 7, 2025
eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
May 6, 2025
Bringing clarity and precision to the cell-free space by introducing exozymes
April 21, 2025
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
April 10, 2025
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
April 2, 2025
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
April 2, 2025
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
March 26, 2025
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
February 21, 2025
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
February 19, 2025